Tivic Health completes Optimization Study for ncVNS device; results due later in 2025

Valion Bio, Inc.

All study visits completed for patent-pending non-invasive cervical vagus nerve stimulation device.
Initial findings reinforce importance of personalization for therapeutic efficacy; detailed results expected later this year.
Earlier findings presented at Bioelectronic Medicine Summit on March 4, 2025.
CEO Jennifer Ernst says breakthroughs increase confidence in novel bioelectronic approach.
Global VNS market forecast at $21.3B by 2030; peripheral nerve stimulation segment growing at 35% CAGR.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.